The enzyme we once feared might actually be a cellular ally

Science · Published 12 October 2026 Swipe more like this →

In short: For years, scientists believed healthy cells deactivated the enzyme telomerase specifically to prevent cancer. However, emerging research suggests this enzyme may play a much more beneficial role in our biology than we previously assumed, challenging our fundamental understanding of cellular protection.

The traditional view of cellular defense has long centered on the idea that healthy cells actively switch off the enzyme telomerase. This deactivation was thought to be a vital safeguard, a way for the body to prevent cells from acquiring the uncontrolled growth characteristics of malignancy. If telomerase remained active, it could potentially provide the immortality required for a tumor to thrive. This protective mechanism is part of a larger biological process where cells manage their own stability. Without such controls, the risk of uncontrolled proliferation increases significantly.

However, new findings are complicating this narrative. Recent studies suggest that telomerase may possess a healthier, more constructive role within our tissues than the 'cancer-promoting' label implies. This shift in perspective suggests that the enzyme's presence might be part of a more nuanced biological balance rather than a simple binary between health and disease. This discovery could reshape how we view cellular longevity and maintenance. Understanding these beneficial functions is essential for future medical breakthroughs.

This re-evaluation of telomerase occurs alongside broader discoveries regarding how our genetic landscape changes under pressure. For instance, researchers from UCL, the Wellcome Sanger Institute, and the University of Cambridge have demonstrated that cancer treatments like chemoradiotherapy can actually alter the mutation landscape in normal tissue. By studying how genes like TP53 and PPM1D respond to treatment, scientists hope to eventually develop therapies that target cancer cells while leaving healthy, vital tissues unharmed. In patients receiving combined chemotherapy, researchers also noted an increase in cells carrying mutations that provide resistance to the drug 5-fluorouracil. Such mutations can actually offer a form of protection against the life-threatening toxicities often caused by chemotherapy.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• How the tiny caps on your chromosomes dictate the speed of your biological aging
• Telomeres act as biological aglets, protecting your genetic code from unraveling every single day.
• How a dyslexic graduate student discovered the enzyme that controls cellular life span
• How a protein on chromosome 5 regulates the biological clock of our cells
• The biological clock may be a mechanical wear-and-tear problem
• The second most-used substance on Earth could be a climate solution
• The visceral moment a Nigerian scientist saw the internet's birth
• Could a common constipation medication help clear depression-related brain fog?
• The scientist who predicted the power of 65,536 cooperating processors
• Is organic chemistry actually as intimidating as it seems?
• How one man turned science fiction into the world's fastest computers
• The 1989 morning that changed how computers solve the world's hardest problems

More in Science · Latest · A–Z · All topics